Changeflow GovPing Healthcare & Life Sciences Effect of TMJ Arthrocentesis on Capsular Width:...
Routine Notice Added Final

Effect of TMJ Arthrocentesis on Capsular Width: An Ultrasonographic Study

Favicon for changeflow.com ClinicalTrials.gov Studies
Detected
Email

Summary

ClinicalTrials.gov registration for NCT07553078, a prospective cohort study at Van Yuzuncu Yil University, Turkey, evaluating the effect of temporomandibular joint arthrocentesis on articular capsular width using ultrasonography. The study received ethics approval (2025/02-07) from Van Yuzuncu Yil University Clinical Research Ethics Committee on February 28, 2025, and is registered as of April 27, 2026. Participants with unilateral intra-articular TMJ disorder receive arthrocentesis with sterile Ringer's lactate solution using a two-needle technique.

“A standard two-needle technique is used, and the upper joint compartment is irrigated with 150-200 mL of sterile Ringer's lactate solution.”

NIH , verbatim from source
Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.

What changed

ClinicalTrials.gov registry entry for NCT07553078, a prospective cohort study conducted at Van Yuzuncu Yil University, Turkey. The study evaluates the effect of temporomandibular joint arthrocentesis on articular capsular width using ultrasonography, with ethical approval from the university dated February 28, 2025. The protocol involves a two-needle arthrocentesis technique irrigating the upper joint compartment with 150-200 mL of sterile Ringer's lactate solution.

This registry entry does not create any new regulatory obligations or compliance requirements for third parties. Healthcare institutions or researchers reviewing this record should note it as an observational clinical study registration with no regulatory change implications.

Archived snapshot

Apr 28, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

EFFECT OF TMJ ARTHROCENTESIS ON ARTICULAR CAPSULAR WIDTH: AN ULTRASONOGRAPHIC STUDY

N/A NCT07553078 Kind: NA Apr 27, 2026

Abstract

This study is designed as a prospective cohort study evaluating the effect of temporomandibular joint arthrocentesis on articular capsular width using ultrasonography. The study is being conducted at the Faculty of Dentistry, Van Yuzuncu Yil University, Turkey, in accordance with the principles of the Declaration of Helsinki. Ethical approval has been obtained from the Van Yuzuncu Yil University Clinical Research Ethics Committee (approval no. 2025/02-07, dated February 28, 2025).

The study includes systemically healthy adult participants with unilateral intra-articular temporomandibular disorder who have not responded adequately to at least six months of conservative management, including medication, occlusal splint therapy, or physiotherapy. Exclusion criteria are systemic rheumatologic diseases, bony or fibrous ankylosis of the temporomandibular joint, previous open temporomandibular joint surgery, pregnancy or breastfeeding, and active infection.

All participants undergo unilateral temporomandibular joint arthrocentesis performed under local anesthesia by a single experienced oral and maxillofacial surgeon. A standard two-needle technique is used, and the upper joint compartment is irrigated with 150-200 mL of sterile Ringer's lactate solution. No pharmacological agents are injected after the lavage. The contralateral, asymptomatic joint serves as an untreated control.

Ultrasonographic and clinical assessments are performed at three time points: baseline before the ...

Conditions: TEMPOROMANDIBULAR JOINT DISORDER

Interventions: Arthrocentesis with ringer solution

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers
Industry sector
5417 Scientific Research
Activity scope
Clinical research
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!